We are live on ! Find out more
BLFS icon

BioLife Solutions

16 hedge funds and large institutions have $653K invested in BioLife Solutions in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

23% more funds holding

Funds holding: 1316 (+3)

11% less capital invested

Capital invested by funds: $736K → $653K (-$83K)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
16
Holders Change
+3
Holders Change %
+23.08%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change

BLFS Hedge Fund Activity: Q1 2016 in Review

16 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2016, worth a combined $653K — down 11% from $736K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BLFS positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $18.9K. The largest seller was UBS Group, cutting an estimated $8.43K.

  • 16 institutional investors held BioLife Solutions (BLFS) as of Q1 2016, up from 13 in Q4 2015.
  • Funds reported $653K of BioLife Solutions stock for Q1 2016, down 11% quarter-over-quarter.
  • 4 funds opened new BioLife Solutions positions in Q1 2016 and 1 closed out, a net change of +3 holders.
  • The largest BioLife Solutions buyer in Q1 2016 was Citadel Advisors, an estimated $18.9K added.
  • The largest BioLife Solutions seller in Q1 2016 was UBS Group, an estimated $8.43K sold.

Based on aggregated 13F filings for Q1 2016.